Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease
Objective: To investigate the effect of dopaminergic medication in Parkinson's disease (PD) on learning to act and learning to withhold action based on rewarding versus…Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET
Objective: To provide insight into the nature of cognitive deterioration and Parkinson's disease dementia (PDD) and to validate a novel cognitive score (also submitted for…Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia
Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…Comparative study patients with different clinical forms of Parkinson’s disease
Objective: To study the cognitive, emotional status, sleep disturbances in patients with akinetic-rigid and tremor form of Parkinson's disease (PD). Background: Parkinson's disease (PD) -…Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease
Objective: We hypothesized that face recognition and color perception may also be impaired after STN DBS and we tested our hypothesis in a group of…Cognitive impairment in patients with progressive supranuclear palsy and multiple system atrophy
Objective: Assessment, description and mutual comparison of cognitive impairment in patients with progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). Background: In most recent…Parkinsonism risk factors in Salt Lake City, Utah
Objective: To assess the prevalence of risk factors for parkinsonism in Salt Lake City (SLC), Utah. Background: Recent data suggest that non-motor symptoms including constipation,…Protein levels of SV2A and VGLUT1 in brain tissue from patients with Parkinson’s disease, dementia with Lewy bodies and Alzheimer’s disease
Objective: The objective of this study was to investigate whether SV2A and/or VGLUT1 are suitable as markers for synaptic degeneration in neurodegenerative disorders and could…Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up
Objective: To investigate the impact of cognition and cognitive decline on quality of life (QoL) in an incident Parkinson's disease (PD) cohort over three years.…Heart rate variability to differentiate dementia with Lewy bodies from Alzheimer’s disease in patients with mild cognitive impairment
Objective: We aimed to determine whether heart rate variability (HRV) can aid in the differentiation of DLB from AD at the MCI stage. Background: Mild…
- « Previous Page
- 1
- …
- 111
- 112
- 113
- 114
- 115
- …
- 117
- Next Page »